Alexander Menzies
MBBS, PhD, FRACP
Associate Professor, Melanoma Institute Australia
👥Biography 个人简介
Alexander Menzies was a principal investigator on the RELATIVITY-047 trial establishing the relatlimab plus nivolumab combination for advanced melanoma, the first approved LAG-3 inhibitor combination. His research also focuses on melanoma brain metastases and the optimal sequencing of IO and targeted therapy for patients with BRAF-mutant metastatic disease. He is deeply involved in Australian melanoma cooperative group trials.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Alexander Menzies 的研究动态
Follow Alexander Menzies's research updates
留下邮箱，当我们发布与 Alexander Menzies（University of Sydney）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment